Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation.
Induction of hepatic metallothionein (MT) synthesis by several nonmetallic compounds and its relationship to an acute-phase response in inflammation were studied in mice. Subcutaneous injections of menadione, paraquat, carbon tetrachloride (CCl4), and several organic solvents caused an increase of hepatic MT concentration. This MT contained only zinc. Menadione and n-hexane caused the greatest accumulation of hepatic MT among these nonmetallic compounds (about 13-fold). The concentration of Zn was significantly decreased in plasma in contrast to liver after an injection of these nonmetallic compounds. When 65ZnCl2 was injected iv after these injections, uptake of 65Zn to the liver was increased. This effect was not observed after treatment with cycloheximide. The association with inflammation of this induction of MT accumulation was examined by determination of acute-phase proteins. The concentration of fibrinogen in the plasma was significantly increased following injection of those nonmetallic compounds which caused marked hepatic MT accumulation. An injection of 1 N NaOH, 1 N HCl, turpentine oil, or endotoxin caused a significant increase in the plasma concentration of fibrinogen and in the hepatic MT concentration. Injections of n-hexane as well as turpentine oil significantly increased hepatic MT concentration and plasma concentration of fibrinogen and ceruloplasmin with time. The concentration of fibrinogen was significantly correlated (r = 0.789) with the concentration of hepatic MT. Neither adrenalectomy nor pretreatment with dexamethasone prevented hepatic MT accumulation caused by these compounds. These results indicate that induction of hepatic MT synthesis by these nonmetallic compounds is associated with an acute-phase response in inflammation and is independent of glucocorticoids.
Min
K S
KS
Department of Nutrition, Kobe-Gakuin University, Japan.
Terano
Y
Y
Onosaka
S
S
Tanaka
K
K
D000209:Acute-Phase Proteins / Q000096:biosynthesis / Q000378:metabolism; D000210:Acute-Phase Reaction / Q000378:metabolism*; D000818:Animals; D005340:Fibrinogen / Q000378:metabolism; D005938:Glucocorticoids / Q000494:pharmacology; D006586:Hexanes / Q000494:pharmacology; D006851:Hydrochloric Acid / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000502:physiology; D008099:Liver / Q000378:metabolism*; D008297:Male; D008668:Metallothionein / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008815:Mice, Inbred Strains; D012972:Sodium Hydroxide / Q000494:pharmacology; D014425:Turpentine / Q000494:pharmacology; D014812:Vitamin K / Q000494:pharmacology; D015032:Zinc / Q000097:blood
D000209:Acute-Phase Proteins; D005938:Glucocorticoids; D006586:Hexanes; D008070:Lipopolysaccharides; D014812:Vitamin K; C026385:n-hexane; D012972:Sodium Hydroxide; D005340:Fibrinogen; D008668:Metallothionein; D015032:Zinc; D006851:Hydrochloric Acid; D014425:Turpentine